Clinical studies have demonstrated that dysregulation of PPAR-γ is related to the development of type 2 diabetes mellitus (T2DM), atherosclerosis [16], osteoporosis [17], and Alzheimer’s disease [18]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.